CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(03): 147-148
DOI: 10.4103/0971-5851.123700
EDITORIAL COMMENTARY

Chronic myeloid leukemia in India

John M Goldman
Department of Haematology, Imperial College London, London, UK
› Author Affiliations


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Goldman JM, Lu DP. New approaches in chronic granulocytic leukemia - Origin, prognosis, and treatment. Semin Hematol 1982;19:241-56.
  • 2 Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, et al. Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood 1984;63:789-99.